global point of care
Improve the way you diagnose diabetes and comorbidities, monitor your patients, and manage their care. The Afinion™ point-of-care system delivers highly accurate results in minutes, in your office, without delays.
Patients with diabetes need prompt diagnosis along with ongoing monitoring and care, and the AfinionTM 2 System is ideal for point-of-care testing (POCT). With its compact size and the range of tests it performs, it’s ideal for POCT in various settings—from physician offices and clinics to community health centers, retirement homes, emergency rooms and hospital outpatient clinics. In 3 easy steps, using a fingerstick-sized sample, you can get accurate results for HbA1c, lipids, and albumin/creatinine ratio (ACR).
The Afinion™ 2 Analyser is the product of continual innovation and refinement, since 2005. The result is enhanced precision: every Afinion 2 System is factory calibrated and released in accordance with stringent specifications. Regarding HbA1c testing quality assurance, for instance, the reliability of the Afinion™ 2 Analyser is demonstrated by meeting all SKUP (Scandinavian Evaluation of Laboratory Equipment for Primary Health Care) quality goals.1
Incorporating POCT can allow for immediate therapy discussions, better patient outcomes, and enhanced clinic efficiencies. Studies2-5 show that testing in the office can increase efficiency by:
“Testing ACR, lipids, and HbA1c in real time using a reliable and accurate point-of-care test is essential. It means I can make treatment decisions based on the latest and most accurate information.”
Diabetes is a complex disease that requires regular monitoring and care. People with diabetes are 2–3 times more likely to have cardiovascular disease (CVD).6 According to international guidelines, lipids and albumin/creatinine ratio (ACR) should be monitored annually.7-8 ACR is known to be a strong predictor for CVD.6,9
The Afinion™ Lipid Panel produces results in 7-8 minutes for total cholesterol (Chol), high-density lipoprotein (HDL) cholesterol, low-density lipoprotein (LDL) cholesterol, triglycerides (Trig), non-HDL, and Chol/HDL ratio. It is certified and accurate to CRMLN standards.10
Since diabetic kidney disease (DKD) is such a serious complication of diabetes, patients’ albumin/creatinine ratio (ACR) should be monitored annually.7,8 A study of type 2 diabetes patients identified 29.3% of patients with DKD, but only 7.8% had this in their medical history.11 As highlighted recently ACR screening rates are extremely low in both diabetes (35%) and hypertension (4%) patients within 2 years.12 This is in contrast to the increasing number of effective therapies to prevent chronic kidney disease-related complications.
An annual assessment of the ACR value in patients with diabetes, as recommended by the guidelines, may positively affect the diagnosis of diabetic kidney disease and subsequently allow better management of patients with diabetes.
A Leader In Rapid Point-of-care Diagnostics.
©2025 Abbott. All rights reserved. Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.
This website is governed by applicable U.S. laws and governmental regulations. The products and information contained herewith may not be accessible in all countries, and Abbott takes no responsibility for such information which may not comply with local country legal process, regulation, registration and usage.
Your use of this website and the information contained herein is subject to our Website Terms and Conditions and Privacy Policy. Photos displayed are for illustrative purposes only. Any person depicted in such photographs is a model. GDPR Statement.
Not all products are available in all regions. Check with your local representative for availability in specific markets. For in vitro diagnostic use only. For i-STAT test cartridge information and intended use, refer to individual product pages or the cartridge information (CTI/IFU) in the i-STAT Support area.
Abbott - A Leader in Rapid Point-of-Care Diagnostics.
